Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Arnie Re: HAUP. I am glad you bought when you did. I assume you paid less than $5 at the time. Do you still have it? I do...I am waiting for a big spike most likely next week.
HAUP $5.78 continues to move up ahead of new products' release.
HAUP (Hauppauge Digital, Inc.) always goes up in the November - February as you can see in the chart.
http://stockcharts.com/gallery/?haup
Typical HAUP late-year catalysts:
* HAUP usually unveils several new products at this time of the year. The CEO already said that will release several new products in coming days/weeks. A product release a year ago at this time of the year lifted the stock 45%.
* 4Q 2006 and FY 2006 earnings to be released in December will show a 20 - 30% year over year revenue increase per CEO's comments last month during the annual meeting. Net income reported for the first 9 months of 2006 is 25c/share, almost doubling the 14c/share reported for all of 2005.
* HAUP usually goes up big during the Consumer Electronics Show held yearly in early January in Las Vegas, Nevada.
* HAUP reports its biggest quarter of the year in February. The first quarter of every year reflects Holiday sales. This year the company expects strong sales of some of its key products.
Interestingly, on 11/20 CEO Plotkin filed that he has acquired 200,000 HAUP shares at $4.96. He now owns 958,000 HAUP shares....or about 10% of all outstanding shares.
This year HAUP is stronger that ever:
- Highest revenue and net income in company history for first 9 months of 2006. Revenues of $76M in 9 months compared to $78M the previous year. Nine month net income of 25c/share compared to 14c/share for the previous year.
- 90c/share cash
- Zero long term debt
- Strong and diverse array of quality products gaining market share worldwide thanks to the simultaneous boom of HDTV, broadband usage, and computer power.
- Strong already in the US and Europe. Gaining market share in the lucrative China/Asia market
- Many recent OEM deals with quality companies like Microsoft, etc.
Even after last week's gain, HAUP is only trading at an undervalued P/S ratio of 0.6......Projected 2006 revenues of $90M+ and only $50M market cap!!!!
Last month Kenneth Plotkin, the Company's Chairman of the Board, Chief Executive Officer, President and Chief Operating Officer said that the Company expected net sales in excess of $90 Million for the fiscal year ended September 30, 2006. He also said that based on certain sales channel market information currently available to the Company, sales of the Company's WinTV-HVR 950 hybrid video recorder product were expected to be relatively strong for the upcoming holiday season. As a reference, revenues for 2005 were $78M.
The Hauppauge WinTV HVR 950 is a small, compact USB device that is capable of viewing and recording both SD and HD TV. The HVR 950 is that it is a self powered USB device. It does not need an external power source to operate, and also comes with a small TV Antenna that is capable of receiving SD (NTSC) and HD (ATSC) over-the-air signals. It is also capable of receiving other NTSC signals, which allows one to view the cable at one's residence.
In the most recent 10Q, the company stated: .."Our R&D departments in New York and Taiwan have been teaming together to deliver an impressive series of new products, including two new multimode TV tuners, the triple TV format WinTV-HVR-3000 and the quadruple TV format WinTV-HVR-4000. The WinTV-HVR-4000 is Hauppauge’s first product with high-definition satellite TV reception. In addition, two new dual tuner digital TV receivers, the WinTV-NOVA-T-500 and the new WinTV-NOVA-T-USB2 diversity digital TV receiver, were introduced. Together, the R&D team is scheduled to introduce 20 new products in fiscal 2006.”.
HAUP (Hauppauge Digital, Inc.) always goes up in the November - February as you can see in the chart.[/B]
http://stockcharts.com/gallery/?haup>
[B]Typical HAUP late-year catalysts[/B]:
* HAUP usually unveils several new products at this time of the year. The CEO already said that will release several new products in coming days/weeks. A product release a year ago lifted the stock 45%.
* 4Q 2006 and FY 2006 earnings to be released in December will show a 20 - 30% year over year revenue increase per CEO's comments last month during the annual meeting. Net income reported for the first 9 months of 2006 is 25c/share, almost doubling the 14c/share reported for all of 2005.
* HAUP usually goes up big during the Consumer Electronics Show held yearly in early January in Las Vegas, Nevada.
* HAUP reports its biggest quarter of the year in February. The first quarter of every year reflects Holiday sales. This year the company expects strong sales of some of its key products.
Interestingly, on 11/20 CEO Plotkin filed that he has acquired 200,000 HAUP shares at $4.96. He now owns 958,000 HAUP shares....or about 10% of all outstanding shares.
[B]This year HAUP is stronger that ever[/B]:
- Highest revenue and net income in company history for first 9 months of 2006. Revenues of $76M in 9 months compared to $78M the previous year. Nine month net income of 25c/share compared to 14c/share for the previous year.
- 90c/share cash
- Zero long term debt
- Strong and diverse array of quality products gaining market share worldwide thanks to the simultaneous boom of HDTV, broadband usage, and computer power.
- Strong already in the US and Europe. Gaining market share in the lucrative China/Asia market
- Many recent OEM deals with quality companies like Microsoft, etc.
Even after last week's gain, HAUP is only trading at an undervalued P/S ratio of 0.6......Projected 2006 revenues of $90M+ and only $50M market cap!!!!
Last month Kenneth Plotkin, the Company's Chairman of the Board, Chief Executive Officer, President and Chief Operating Officer said that the Company expected net sales in excess of $90 Million for the fiscal year ended September 30, 2006. He also said that based on certain sales channel market information currently available to the Company, sales of the Company's WinTV-HVR 950 hybrid video recorder product were expected to be relatively strong for the upcoming holiday season. As a reference, revenues for 2005 were $78M.
The Hauppauge WinTV HVR 950 is a small, compact USB device that is capable of viewing and recording both SD and HD TV. The HVR 950 is that it is a self powered USB device. It does not need an external power source to operate, and also comes with a small TV Antenna that is capable of receiving SD (NTSC) and HD (ATSC) over-the-air signals. It is also capable of receiving other NTSC signals, which allows one to view the cable at one's residence.
In the most recent 10Q, the company stated: .."Our R&D departments in New York and Taiwan have been teaming together to deliver an impressive series of new products, including two new multimode TV tuners, the triple TV format WinTV-HVR-3000 and the quadruple TV format WinTV-HVR-4000. The WinTV-HVR-4000 is Hauppauge’s first product with high-definition satellite TV reception. In addition, two new dual tuner digital TV receivers, the WinTV-NOVA-T-500 and the new WinTV-NOVA-T-USB2 diversity digital TV receiver, were introduced. Together, the R&D team is scheduled to introduce 20 new products in fiscal 2006.”.
HAUP $4.4 Filing 11/20. CEO Plotkin acquires 200,000 shares at $4.96!!!!
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001253067%2D06%2D000010%2Etxt&FilePath...
That was HAUP...sorry. Lat trade $4.4 ...up 44c.
HUAP breakout resuming after a shor-lived dip. Last trade $5.38
HAUP Broke through a major resistance at $5.05 today. I expect a significant spike after the company announces the launch of new products in time for Christmas shopping season
http://stockcharts.com/gallery/?haup
The recent climb to $6+ was due to better than expected 3Q 2006 results and unrelated to the usual November - February rally.
HAUP $5.3 up 36c...Broke major Resistance. I expect a significant spike after the company announces the launch of new products in time for Christmas shopping season
HAUP (Hauppauge Digital, Inc.) always goes up in the November - February ...see lower chart:
http://stockcharts.com/gallery/?haup
The recent climb to $6+ was due to better than expected 3Q 2006 results and unrelated to the usual November - February rally.
This year HAUP is stronger that ever in its history:
- Highest revenue and net income in company history for first 9 months of 2006.
Revenues of $76M in 9 months compared to $78M the previous year. Nine month net income of 25c/share compared to 14c/share for the previous year.
- 90c/share cash
- Zero long term debt
- Strong and diverse array of quality products gaining market share worldwide thanks to the simultaneous boom of HDTV, broadband usage, and computer power.
- Strong already in the US and Europe. Gaining market share in the lucrative China/Asia market
- Many recent OEM deals with quality companies like Microsoft, etc.
And it is only trading at a P/S ratio of 0.6......Projected 2006 revenues of $90M+ and only $50M market cap!!!!
Typical HAUP late-year catalysts:
* HAUP usually unveils several new products at this time of the year. The CEO already said that will release several new products in coming days/weeks. A product release a year ago lifted the stock 45%.
* 4Q 2006 and FY 2006 earnings to be released in December will show a 20 - 30% year over year revenue increase per CEO's comments last month during the annual meeting. Net income reported for the first 9 months of 2006 is 25c/share, almost doubling the 14c/share reported for all of 2005.
* HAUP usually goes up big during the Consumer Electronics Show held yearly in early January in Las Vegas, Nevada.
* HAUP reports its biggest quarter of the year in February. The first quarter of every year reflects Holiday sales. This year the company expects strong sales of some of its key products.
Last month Kenneth Plotkin, the Company's Chairman of the Board, Chief Executive Officer, President and Chief Operating Officer said that the Company expected net sales in excess of $90 Million for the fiscal year ended September 30, 2006. He also said that based on certain sales channel market information currently available to the Company, sales of the Company's WinTV-HVR 950 hybrid video recorder product were expected to be relatively strong for the upcoming holiday season. As a reference, revenues for 2005 were $78M.
The Hauppauge WinTV HVR 950 is a small, compact USB device that is capable of viewing and recording both SD and HD TV. The HVR 950 is that it is a self powered USB device. It does not need an external power source to operate, and also comes with a small TV Antenna that is capable of receiving SD (NTSC) and HD (ATSC) over-the-air signals. It is also capable of receiving other NTSC signals, which allows me to view the cable at one's residence.
The WinTVHVR 950 is a truly portable TV Tuner from which you can view TV virtually anywhere. Your apartment, the park, hotel room, and even an airport terminal could provide the signal quality and reception that you need in order to view TV with this device.
In the most recent 10Q, the company stated: .."Our R&D departments in New York and Taiwan have been teaming together to deliver an impressive series of new products, including two new multimode TV tuners, the triple TV format WinTV-HVR-3000 and the quadruple TV format WinTV-HVR-4000. The WinTV-HVR-4000 is Hauppauge’s first product with high-definition satellite TV reception. In addition, two new dual tuner digital TV receivers, the WinTV-NOVA-T-500 and the new WinTV-NOVA-T-USB2 diversity digital TV receiver, were introduced. Together, the R&D team is scheduled to introduce 20 new products in fiscal 2006.”
...
HAUP at $4.8 might be a bargain at these prices. I am loading up for good times ahead.
HAUP (Hauppauge Digital, Inc.) always goes up in the November - February time frame because of a combination of several factors.
http://stockcharts.com/gallery/?haup
Take a look at the lower or weekly chart to clearly see that behavior. This year HAUP is stronger that ever in its history
Typical HAUP late-year catalysts:
* HAUP usually unveils several new products at this time of the year. The CEO already said that will release several new products in coming days/weeks
* 4Q 2006 and FY 2006 earnings to be released in December will show a 20 - 30% year over year revenue increase per CEO's comments last month during the annual meeting. Net income reported for the first 9 months of 2006 is 25c/share, almost doubling the 14c/share reported for all of 2005.
* HAUP usually goes up big during the Consumer Electronics Show held yearly in early January in Las Vegas, Nevada.
* HAUP reports its biggest quarter of the year in February. The first quarter of every year reflects Holiday sales. This year the company expects strong sales of some of its key products.
Last month Kenneth Plotkin, the Company's Chairman of the Board, Chief Executive Officer, President and Chief Operating Officer said that the Company expected net sales in excess of $90 Million for the fiscal year ended September 30, 2006. He also said that based on certain sales channel market information currently available to the Company, sales of the Company's WinTV-HVR 950 hybrid video recorder product were expected to be relatively strong for the upcoming holiday season. As a reference, revenues for 2005 were $78M.
The Hauppauge WinTV HVR 950 is a small, compact USB device that is capable of viewing and recording both SD and HD TV. The HVR 950 is that it is a self powered USB device. It does not need an external power source to operate, and also comes with a small TV Antenna that is capable of receiving SD (NTSC) and HD (ATSC) over-the-air signals. It is also capable of receiving other NTSC signals, which allows me to view the cable at one's residence.
The WinTVHVR 950 is a truly portable TV Tuner from which you can view TV virtually anywhere. Your apartment, the park, hotel room, and even an airport terminal could provide the signal quality and reception that you need in order to view TV with this device. The Hauppauge WinTV HVR 950 USB2 is a TV Tuner that gives hope to the masses of people that have non-Media Center PCs. It is fairly compact, and provides both a quality SDTV and HDTV experience to the end user.
This product (about $100) is a hot selling item and almost impossible to find on shelves of electronics stores worldwide.
In the most recent 10Q, the company stated: .."Our R&D departments in New York and Taiwan have been teaming together to deliver an impressive series of new products, including two new multimode TV tuners, the triple TV format WinTV-HVR-3000 and the quadruple TV format WinTV-HVR-4000. The WinTV-HVR-4000 is Hauppauge’s first product with high-definition satellite TV reception. In addition, two new dual tuner digital TV receivers, the WinTV-NOVA-T-500 and the new WinTV-NOVA-T-USB2 diversity digital TV receiver, were introduced. Together, the R&D team is scheduled to introduce 20 new products in fiscal 2006.”
Other HAUP facts:
- Small float of about 5M shares
- Strong balance sheet: $8M cash or 90c/share and ZERO LT DEBT
- Profitable and growing company. Last three year revenues are: $51M in 2003, $65M in 2004, and $78M in 2005 ended in September 2005....and over $90M in 2006 (per recent guidance)
- Profitable every quarter this year
- Highest yearly profit to be reported in a few weeks (2006)
- Undervalued. Trading at a P/S ratio of about 0.5.
- Technological leader in the development and manufacturing of digital TV and data broadcast receiver products for personal computers.
- Institutional ownership is way up!!:
For more info go to the Hauppauge web page...
http://www.hauppauge.com/
DYNT $1.4...Earnings tomorrow morning...Bulls and Bears frozen so far..i believe that the bulls will win tomorrow and in the weeks ahead.
http://stockcharts.com/gallery/?dynt
Keep an eye on DYNT...strong 1Q 2007 earnings/guidance are expected tomorrow...Target: $3+ within 3 months.
Guidance for 2Q 2007 will be even stronger. The CEO already said in the last CC that 2Q 2007 will be a breakout quarter.
The last time that happened, the stock went from $1.3 to $4+ from November to February....see the lower weekly chart above.
For 2007 management expects a 10%+ revenue growth due to an unprecedent number of new-generation products recently released. Net income will improve dramatically as well because the company plans to cut down the record 2006 R$D costs by about 5c/share to historical levels.
My revenue estimate for 1Q 2007 is of $5M+ and about 2 - 4c/share net income. This compares favorably with $4.3M in revenues reported in 1Q 2006 and a rare (although small $22K) loss. 1Q 2007 numbers should also beat 4Q 2006 handily both in revenues and net income.
DYNT will likely generate a net income of about 15c/share in 2007. This is because the margins for the new products will be higher and the company will reduce R&D expenses by about 5c/share
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
DYNT is one of the safest stock you will find under $2. The company believes the stock is too undervalued and they have a stock buyback that they activate when the stock reaches under $1.3. They bought over 50,000 shares this year and have money approved for about 250,000 more shares
DYNT predicted at least 10% revenue increase for 2007 compared to 2006. 2006 was a year of transition and they invested a record $1.7M in R&D. This led to the recent release of many new products....the highest number of new products in company history.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
DYNT is the leader in light therapy technology for pain management. DYNT's Light therapy products are FDA-approved.
DYNT made big news 2 years ago when one of DYNT's light probe was used fix Terrell Owens foot. He was expected to miss the playoffs, however, thanks to DYNT therapy the psycho was able to play and shine big time in the Superbowl. They should used the probe to fix his brain instead
EXXA $4.1...I expext that EXXA will report another blockbuster quarter this week. EXXA could jump to $10++ after earnings....many less deserving low flloaters with a lot less earnings have done just that.
6-month target: $15++.
http://stockcharts.com/gallery/?EXX/A
$10++??...WHY??.... How about 60 - 80c/share annualized net income.....trading at 0.25 P/S.....About $170M/year in revenues....Only $42M market cap....solid balance sheet with $1.3/share cash....float of only 4.7M shares...long-term debt disappearing fast
EXXA will likely make an annualized 60 - 80c/share net income due to two major long-term contracts with DaimlerCrysler and the recent acquisition of profitable vinyl wallpaper maker Sellers & Josephson from Chapter 11.
In August 2006, EXX Inc. (AMEX: EXXA...or EXX/A or EXX.A) reported an impressive 19c/share net income on $43M in revenues (about 20% revenue growth) for 2Q 2006.
Take a look at EXXA's steady improvement quarter after quarter.
http://finance.yahoo.com/q/is?s=EXX-A
EXXA has a strong balance sheet with $1.3 in cash and a rapidly diminishing long-term debt having been reduced three-fold in the last 3 years:
http://finance.yahoo.com/q/bs?s=EXX-A
DaimlerChrysler has recently become EXXA's largest customer due to two significant multi-year contracts amounting to about $45M in revenues. The new DaimlerChrysler's contracts will represent about 25 % of the total projected $160M - $180M/year EXXA revenues in 2006.
Regarding the two DaimlerChrysler contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
Another factor for EXXA's big jump in revenues and profitability is its recent acquisition of vinyl wallpaper maker Sellers & Josephson (S&J) from BK for $4M. S&J was a division of Falcon Products, which went bankrupt, but S&J was making money. In short, EXXA bought a profitable company for less than net tangible assets.
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A.
EXXA was a $6+ stock in 2004 with less revenues, less earnings, and three times the long-term debt. More importantly, EXXA did not have a blue chip company like DaimlerChrysler as its largest customer.
It is obvious that EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $44 MILLION
* INSIDERS OWN 54% OF COMPANY
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003........
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing for the automotive, heavy-duty, agricultural, industrial, and defense markets. Newcor also operates the Bay City Division, which designs and builds state-of-art welding and forming equipment.
The following link describes some of Bay City Automotive-component development and production capabilities..
http://www.baycity.newcor.com/autocomp.html
*** Always do your own DD and invest at your own risk
DYNT $1.44....Nice!!!....already 5 times the average trading volume and an 8% gain so far. We still have several trading hours today. Momentum players will start flocking into this one.
I fully expect DYNT to behave like it did 2 years ago when it went from $1.3 to $4 in about three months...see the chart below....bottom weekly chart:
http://stockcharts.com/gallery/?dynt
DYNT $1.44 now...up 9%...volume increasing.
Erehwontim..Re: DYNT. The first sentence refers to last year. The DX2 was launched in September as scheduled. According to the company sales of this broduct are strong. They decided not to issue a PR for it because they "did not want to pump the stock" because the PR for the DX3 released earlier in the quarter comtain similar wording.
Good luck. I am not selling until it reaches $3 in February...during the CC the CEO said that 2Q will be a breakout quarter
DYNT $1.39 moving up ahead of earnings Thursday (today's company announcement)
Earnings for 1Q 2007 will likely be strong.... Guidance for 2Q 2007 even stronger.
I expect a 30 -50% gain after earnings and a 100 - 300% gain over the next 3 - 4 months.
WHY??
I expect over $5M in revenues and about 4c/share net income for 1Q 2007. This compares favorable with $4.3M reported in 1Q 2006 and a rare (although small $22K) loss...and also a significant improvement over 4Q 2006. I expect guidance for 2Q 2007 to be very bullish since all new products recently launched will have a complete quarter of sales. I fully expect DYNT to behave like it did 2 years ago when it went from $1.3 to $4 in about three months...see the chart below....bottom weekly chart:
http://stockcharts.com/gallery/?dynt
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
DYNT is one of the safest stock you will find under $2. The company believes the stock is too undervalued and they have a stock buyback that they activate when the stock reaches under $1.3. They do that to prevent manipulation and to get too close to $1. They bought over 50,000 shares this year and have money approved for about 250,000 more shares
Now this company is ready to turn the corner. They predicted at least 10% revenue increase for 2007 compared to 2006. 2006 was a year of transition and they invested a record $1.7M in R&D. This led to the recent release of many new products....the highest number of new products in company history.
In addition to a healthy revenue growth, DYNT is likely to produce a net income of about 15c/share in 2007. This is because the margins for the new products will be higher and the company will reduce R&D expenses by about 5c/share.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
DYNT is the leader in light therapy technology for pain management. DYNT's Light therapy products are FDA-approved.
Light Therapy (replaces VIOXX, Celebrex, etc) is non-invasive and has no side effects. It has been used extensively throughout the world for more than twenty years.
DYNT made big news 2 years ago when it was learnt that one of DYNT's light probes was used to to fix Terrell Owens foot. He was expected to miss the playoffs, however, he had a miraculous recovery and was able to play and shine big time in the Superbowl
DYNT $1.25..Reminder: 1Q 2007 earnings next week.
Next week's 1Q 2007 numbers will be stronger than most recent quarters, and the start of a series of even stronger quarters. Company expects at least 10% revenue growth for 2007 compared to 2006. Net income will likely be about 15c/share in 2007
For 1Q 2007, I expect over $5M in revenues and about 4c/share net income. Compare that with $4.3M reported in 1Q 2006 and a rare (although small $22K) loss.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
DYNT is one of the safest stock you will find under $2. The company believes the stock is too undervalued and they have a stock buyback that they activate when the stock reaches under $1.3. They do that to prevent manipulation and to get too close to $1. They bought over 50,000 shares this year and have money approved for about 250,000 more shares
Now this company is ready to turn the corner. They predicted at least 10% revenue increase for 2007 compared to 2006. 2006 was a year of transition and they invested a record $1.7M in R&D. This led to the recent release of many new products....the highest number of new products in company history.
In addition to a healthy revenue growth, DYNT is likely to produce a net income of about 15c/share in 2007. This is because the margins for the new products will be higher and the company will reduce R&D expenses by about 5c/share.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved.
Light Therapy (replaces VIOXX, Celebrex, etc) is non-invasive and has no side effects. It has been used extensively throughout the world for more than twenty years.
Remember when Terrell Owens got injured before the Superbowl a few years ago and it appear that he was going to miss the playoffs?...they used DYNT's light probes to enable this azzhole to get well quickly and shine big time in the Superbowl. At the time it was dubbed a miracle cure...the stock went to $3 in a hurry.....................
DYNT $1.28...Earnings next week...and will be good. The company has released an umprecedented 10 new high-margin products in recent months. These new products will increase revenues by at least 10% according to management. With a reduction of R&D from record levels DYNT will likely earn 15c/share in 2007.
Here is an example of one such product:
http://www.barringtonequipment.com/file.asp?f=EEA87801C92441A3B27E427E9CA59D22.pdf&n=DX9_1.pdf&a...
DYNT is one of the safest stock you will find under $2. The company believes the stock is too undervalued and they have a stock buyback that they activate when the stock reaches under $1.3. They do that to prevent manipulation and to get too close to $1. They bought over 50,000 shares this year and have money approved for about 250,000 more shares
Now this company is ready to turn the corner. They predicted at least 10% revenue increase for 2007 compared to 2006. 2006 was a year of transition and they invested a record $1.7M in R&D. This led to the recent release of many new products....the highest number of new products in company history. These products will start showing their positive effect on revenues and net income starting with 1Q 2007 to be reported in early November.
In addition to a healthy revenue growth, DYNT is likely to produce a net income of about 15c/share in 2007. This is because the margins for the new products will be higher and the company will reduce R&D expenses by about 5c/share.
DYNT has a strong balance sheet, a low float, and it is currently trading at a very low 0.5 P/s for a profitable company with strong growth prospects.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
DYNT $1.32 is moving up ahead of earnings.
http://stockcharts.com/gallery/?dynt
DYNT is one of the safest stock you will find under $2. The company believes the stock is too undervalued and they have a stock buyback that they activate when the stock reaches under $1.3. They do that to prevent manipulation and to get too close to $1. They bought over 50,000 shares this year and have money approved for about 250,000 more shares
Now this company is ready to turn the corner. They predicted at least 10% revenue increase for 2007 compared to 2006. 2006 was a year of transition and they invested a record $1.7M in R&D. This led to the recent release of many new products....the highest number of new products in company history. These products will start showing their positive effect on revenues and net income starting with 1Q 2007 to be reported in early November.
In addition to a healthy revenue growth, DYNT is likely to produce a net income of about 15c/share in 2007. This is because the margins for the new products will be higher and the company will reduce R&D expenses by about 5c/share.
DYNT has a strong balance sheet, a low float, and it is currently trading at a very low 0.5 P/s for a profitable company with strong growth prospects.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
EXXA $4.3. New solid base forming in the $4.3 - $4.5 range before a major breakout after another blockbuster quarter. 6-month target: $15++.
http://stockcharts.com/gallery/?EXX/A
A few reasons for the rally?? High expectations coupled with recent awareness that EXXA even existed. 60 - 80c/share annualized net income.....trading at 0.25 P/S.....solid balance sheet with $1.3/share cash....float of only 4.7M shares.
EXXA is starting to to move up ahead of another huge quarter to be reported in about three weeks. EXXA will likely make an annualized 60 - 80c/share net income due to two major long-term contracts with DaimlerCrysler and the recent acquisition of profitable vinyl wallpaper maker Sellers & Josephson from Chapter 11.
In August 2006, EXX Inc. (AMEX: EXXA...or EXX/A or EXX.A) reported an impressive 19c/share net income on $43M in revenues (about 20% revenue growth) for 2Q 2006.
Take a look at EXXA's steady improvement quarter after quarter.
http://finance.yahoo.com/q/is?s=EXX-A
EXXA has a strong balance sheet with $1.3 in cash and a rapidly diminishing long-term debt having been reduced three-fold in the last 3 years:
http://finance.yahoo.com/q/bs?s=EXX-A
DaimlerChrysler has recently become EXXA's largest customer due to two significant multi-year contracts amounting to about $45M in revenues. The new DaimlerChrysler's contracts will represent about 25 % of the total projected $160M - $180M/year EXXA revenues in 2006.
Regarding the two DaimlerChrysler contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
Another factor for EXXA's big jump in revenues and profitability is its recent acquisition of vinyl wallpaper maker Sellers & Josephson (S&J) from BK for $4M. S&J was a division of Falcon Products, which went bankrupt, but S&J was making money. In short, EXXA bought a profitable company for less than net tangible assets.
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A.
EXXA was a $6+ stock in 2004 with less revenues, less earnings, and three times the long-term debt. More importantly, EXXA did not have a blue chip company like DaimlerChrysler as its largest customer.
It is obvious that EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $44 MILLION
* INSIDERS OWN 54% OF COMPANY
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003........
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing for the automotive, heavy-duty, agricultural, industrial, and defense markets. Newcor also operates the Bay City Division, which designs and builds state-of-art welding and forming equipment.
The following link describes some of Bay City Automotive-component development and production capabilities..
http://www.baycity.newcor.com/autocomp.htm
*** Always do your own DD and invest at your own risk
DYNT broke the $1.31 resistance on Friday on relatively high volume for this stock.
http://stockcharts.com/gallery/?dynt
DYNT is one of the safest stock you will find under $2. The company believes the stock is too undervalued and they have a stock buyback that they activate when the stock reaches under $1.3. They do that to prevent manipulation and to get too close to $1. They bought over 50,000 shares this year and have money approved for about 250,000 more shares
Now this company is ready to turn the corner. They predicted at least 10% revenue increase for 2007 compared to 2006. 2006 was a year of transition and they invested a record $1.7M in R&D. This led to the recent release of many new products....the highest number of new products in company history. These products will start showing their positive effect on revenues and net income starting with 1Q 2007 to be reported in early November.
In addition to a healthy revenue growth, DYNT is likely to produce a net income of about 15c/share in 2007. This is because the margins for the new products will be higher and the company will reduce R&D expenses by about 5c/share.
DYNT has a strong balance sheet, a low float, and it is currently trading at a very low 0.5 P/s for a profitable company with strong growth prospects.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
DYNT $1.3 might breakout any minute. Radar it.
EXXA $4.44 Keeps looking strong in anticipation of potential blockbuster earnings in 2 weeks
DYNT $1.28..Strong and profitable 2007 expected by CEO...Stock buyback in progress...Low float...Strong balance sheet....Trading at 0.6 P/S
EARNINGS IN LESS THAN 3 WEEKS.
6-month Target:$3
Dynatronics (Nasdaq: DYNT) recently reported another profitable year for FY 2006. 2007 is looking like it will be a strong year for DYNT.
The company started shipping two new products during the first quarter to be reported in less than 4 weeks (ending September 30). According to the company the DX2 started shipping in late September as announced in the 4Q CC. Sales of this revolutionary products have been brisk according to the Company. The DX3 light therapy unit started shipping earler in the quarter.
DYNT's CEO predicted at least 10% revenue growth and a substantial increase in net income.....
From the earnings release and CC:
-- DYNT was profitable again. The company invested an all-time record amount in R&D in 2006.
-- The positive effect of the many new products launched, and to be launched in the next few weeks, on revenues and net income will start showing up in Q1 2007 to be reported in early November 2006.
-- DYNT will lower R&D expenses by about 5c/share in 2007 from 2006's record levels.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
-- The company believes the stock is undervalued and has triggered its stock-buyback program. About 50K shares have been purchased in the open market in 2006. DYNT has cash authorized to buy 250K more shares. the company activates its buyback program when the stock dips under $1.3.
-- Two major new products will be launched in October/November 2006.
-- Based on the new product launches and reduced R&D costs, DYNT expects at least a 10% revenue growth and substatially higher net income. I believe net income will range from 10 -15c/share in 2007.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
EXXA $4.4 is setting a new higher baseline ahead of huge earnings in less than 3 weeks.
6-month target: $15++.
http://stockcharts.com/gallery/?EXX/A
A few reasons??....60 - 80c/share annualized net income.....trading at 0.25 P/S.....Solid balance sheet with $1.3/share cash....float of only 4.7M shares.
EXXA is starting to to move up ahead of another huge quarter to be reported in about three weeks. EXXA will likely make an annualized 60 - 80c/share net income due to two major long-term contracts with DaimlerCrysler and the recent acquisition of profitable vinyl wallpaper maker Sellers & Josephson from Chapter 11.
In August 2006, EXX Inc. (AMEX: EXXA...or EXX/A or EXX.A) reported an impressive 19c/share net income on $43M in revenues (about 20% revenue growth) for 2Q 200. Here is the link for the
Take a look at EXXA's steady improvement quarter after quarter.
http://finance.yahoo.com/q/is?s=EXX-A......
EXXA has a strong balance sheet with $1.3 in cash and a rapidly diminishing long-term debt having been reduced three-fold in the last 3 years.
DaimlerChrysler has recently become EXXA's largest customer due to two significant multi-year contracts amounting to about $45M in revenues. The new DaimlerChrysler's contracts will represent about 25 % of the total projected $160M - $180M/year EXXA revenues in 2006.
Regarding the two DaimlerChrysler contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
Another factor for EXXA's big jump in revenues and profitability is its recent acquisition of vinyl wallpaper maker Sellers & Josephson (S&J) from BK for $4M. S&J was a division of Falcon Products, which went bankrupt, but S&J was making money. In short, EXXA bought a profitable company for less than net tangible assets.
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A.
It is obvious that EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $44 MILLION
* INSIDERS OWN 54% OF COMPANY
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003........
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing for the automotive, heavy-duty, agricultural, industrial, and defense market
Re: EXXA Symbol. The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers.
Here are a few
Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A.
I understand the company will seek Nasdaq listing. That will add fuel to the fire.
Ooops!! Spoke too soon..EXXA is now $4.55!!!!!
EXXA $3.39...UP 16c....the pre-earnings rally continues. Enough said.
EXXA $4.24. Pre-earnings rally continues relentlessly. 6-month target: $15++.
http://stockcharts.com/gallery/?EXX/A
A few reasons for the rally?? High expectations coupled with recent awareness that EXXA even existed. 60 - 80c/share annualized net income.....trading at 0.25 P/S.....solid balance sheet with $1.3/share cash....float of only 4.7M shares.
EXXA is starting to to move up ahead of another huge quarter to be reported in about three weeks. EXXA will likely make an annualized 60 - 80c/share net income due to two major long-term contracts with DaimlerCrysler and the recent acquisition of profitable vinyl wallpaper maker Sellers & Josephson from Chapter 11.
In August 2006, EXX Inc. (AMEX: EXXA...or EXX/A or EXX.A) reported an impressive 19c/share net income on $43M in revenues (about 20% revenue growth) for 2Q 2006.
Take a look at EXXA's steady improvement quarter after quarter.
http://finance.yahoo.com/q/is?s=EXX-A
EXXA has a strong balance sheet with $1.3 in cash and a rapidly diminishing long-term debt having been reduced three-fold in the last 3 years:
http://finance.yahoo.com/q/bs?s=EXX-A
DaimlerChrysler has recently become EXXA's largest customer due to two significant multi-year contracts amounting to about $45M in revenues. The new DaimlerChrysler's contracts will represent about 25 % of the total projected $160M - $180M/year EXXA revenues in 2006.
Regarding the two DaimlerChrysler contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
Another factor for EXXA's big jump in revenues and profitability is its recent acquisition of vinyl wallpaper maker Sellers & Josephson (S&J) from BK for $4M. S&J was a division of Falcon Products, which went bankrupt, but S&J was making money. In short, EXXA bought a profitable company for less than net tangible assets.
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A.
EXXA was a $6+ stock in 2004 with less revenues, less earnings, and three times the long-term debt. More importantly, EXXA did not have a blue chip company like DaimlerChrysler as its largest customer.
It is obvious that EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $44 MILLION
* INSIDERS OWN 54% OF COMPANY
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003........
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing for the automotive, heavy-duty, agricultural, industrial, and defense markets...........
EXXA $3.92......Due diligence without caps!!!!
EXXA was AMEX largest % gainer last week. 6-month target: $15++
http://stockcharts.com/gallery/?EXX/A
The stock is starting to to move up ahead of another huge quarter to be reported in about three weeks. EXXA will likely make an annualized 60 - 80c/share net income due to two major long-term contracts with DaimlerCrysler and the recent acquisition of profitable vinyl wallpaper maker Sellers & Josephson from Chapter 11.
EXXA has $1.3/cash and trades at a meager 0.25 P/S even with the recent gains. EXXA will likely rocket after earnings because its public float is made up of only 4.7M shares; it is still grossly undervalued; and has made it to many investors' radar screen. This is evident by looking at the recent price/volume increase compared to recent historical levels.
In August 2006, EXX Inc. (AMEX: EXXA...or EXX/A or EXX.A) reported an impressive 19c/share net income on $43M in revenues (about 20% revenue growth) for 2Q 200. Here is the link for the
Take a look at EXXA's steady improvement quarter after quarter.
http://finance.yahoo.com/q/is?s=EXX-A
EXXA has a strong balance sheet with $1.3 in cash and a rapidly diminishing long-term debt having been reduced three-fold in the last 3 years.
http://finance.yahoo.com/q/bs?s=EXX-A
DaimlerChrysler has recently become EXXA's largest customer due to two significant multi-year contracts amounting to about $45M in revenues. The new DaimlerChrysler's contracts will represent about 25 % of the total projected $160M - $180M/year EXXA revenues in 2006.
Regarding the two DaimlerChrysler contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
Another factor for EXXA's big jump in revenues and profitability is its recent acquisition of vinyl wallpaper maker Sellers & Josephson (S&J) from BK for $4M. S&J was a division of Falcon Products, which went bankrupt, but S&J was making money. In short, EXXA bought a profitable company for less than net tangible assets.
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A.
EXXA was a $6+ stock in 2004 with less revenues, less earnings, and three times the long-term debt. More importantly, EXXA did not have a blue chip company like DaimlerChrysler as its largest customer.
It is obvious that EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $44 MILLION
* INSIDERS OWN 54% OF COMPANY
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003.
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing of a variety of products, principally for the automotive, heavy-duty, agricultural, industrial, and defense markets.
Cheverrox Re. EXXA ($3.92). I agree with your comments 100%. I believe that EXXA will be able to support a $10+ valuation after another strong quarter. We will know this in less than a month. I believe insiders know that the numbers are really good. The volume/price has gone way up in the last few days right after the books for the quarter closed. I know one thing....no one is selling for less than $6.
With a forward annualized net income of up t0 80c/share; $1.3/share cash; currently trading at 0.25 P/S; with less than 4M shares on the float.....even with a 25% gain last week, EXXA is easily one of the most undrevalued stocks in the market today.
EXXA $3.92...2-year highs each day last week. Radar it
EXX/A IS STARTING TO MOVE UP AHEAD OF ANOTHER BLOCKBUSTER QUARTER TO BE REPORTED IN 3 WEEKS. EXXA WAS AMEX LARGEST % GAINER LAST WEEK.
http://stockcharts.com/gallery/?EXX/A
6-MONTH TARGET: $15++
IN AUGUST 2006, EXX INC. (AMEX: EXXA...or EXX/A or EXX.A) REPORTED AN IMPRESSIVE 19C/SHARE NET INCOME ON $43M IN REVENUES or ABOUT 20% REVENUE GROWTH....
TAKE A LOOK AT EXXA'S STEADY IMPROVEMENT QUARTER AFTER QUARTER:
http://finance.yahoo.com/q/is?s=EXX-A......
IN ADDITION OF GREAT EARNINGS, EXXA HAS A STRONG BALANCE SHEET WITH $1.3/SHARE CASH. EXXA HAS REDUCED ITS LONG-TERM DEBT THREE-FOLD IN THE LAST 3 YEARS!!!!
http://finance.yahoo.com/q/bs?s=EXX-A......
DAIMLERCHRYSLER IS NOW EXXA'S LARGEST CUSTUMER WITH TWO HUGE CONTRACTS ($45M/YR REVENUES)ANNOUNCED LAST YEAR. DCX PROFITS ARE STARTING SHOW UP BIG TIME IN THE TOP AND BOTTOM LINES. THIS IS THE FIRST OF SEVERAL SIMILAR BLOCKBUSTER QUARTERS. THE ESTIMATED FULL YEAR NET INCOME IS 60 - 80C/SHARE.
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $40 MILLION
* INSIDERS OWN 54% OF COMPANY
EXXA was a $6+ stock in 2004 with less revenues, less earnings, and three times the long-term debt. More importantly, EXXA did not have a blue chip company like DaimlerChrysler as its largest customer.
2Q 2006 EARNINGS SUMMARY:
REVENUES: $43M .....vs. $37M....2ND QUARTER
NET INCOME: $2.14M OR 19C/SHARE..........vs. $0.7M LAST YEAR
DaimlerChrysler is now Exx Inc.'s largest customer. The new DaimlerChrysler's contracts will represent about 30 % of the total projected $160M - $180M/year EXXA revenues in 2006.
EXXA has the potential to become the next BOOM. In 2005 Fortune Magazine ranks EXXA as No. 1 in revenue growth, and 8th overall, among America's fastest growing companies.
About The Two DaimlerChrysler Contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A
EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003. EXXA recently bought vinyl wallpaper maker Sellers & Josephson (S&J) from BK ofr $4M. EXXA expects S&J to be immediately acreetive to earnings and net income.
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing of a variety of products, principally for the automotive, heavy-duty, agricultural, industrial, and defense markets.
EXXA $3.18........A CHART IS WORTH 1000 WORDS........EXX/A IS STARTING TO MOVE UP AHEAD OF ANOTHER BLOCKBUSTER QUARTER
http://stockcharts.com/gallery/?EXX/A
IN AUGUST 2006, EXX INC. (AMEX: EXXA...or EXX/A or EXX.A) REPORTED A BLOCKBUSTER 2Q 2007 NETTING AN IMPRESSIVE 19C/SHARE NET INCOME ON $43M IN REVENUES or ABOUT 20% REVENUE GROWTH....
THE NEXT SEVERAL QUARTERS WILL BE JUST AS STRONG AS 2Q. 2Q WILL BE REPORTED IN ABOUT 4 WEEKS. TAKE A LOOK AT EXXA'S STEADY IMPROVEMENT QUARTER AFTER QUARTER:
http://finance.yahoo.com/q/is?s=EXX-A
IN ADDITION OF GREAT EARNINGS, EXXA HAS A STRONG BALANCE SHEET WITH $1.3/SHARE CASH. EXXA HAS REDUCED ITS LONG-TERM DEBT THREE-FOLD IN THE LAST 3 YEARS!!!!
http://finance.yahoo.com/q/bs?s=EXX-A
DAIMLERCHRYSLER IS NOW EXXA'S LARGEST CUSTUMER WITH TWO HUGE CONTRACTS ($45M/YR REVENUES)ANNOUNCED LAST YEAR. DCX PROFITS ARE STARTING SHOW UP BIG TIME IN THE TOP AND BOTTOM LINES. THIS IS THE FIRST OF SEVERAL SIMILAR BLOCKBUSTER QUARTERS. THE ESTIMATED FULL YEAR NET INCOME IS 60 - 80C/SHARE.
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2006 ESTIMATED REVENUES: $170 MILLION...25% GROWTH
* 2006 ESTIMATED NET INCOME: 50 - 60C/SHARE
* ESTIMATED FULL YEAR NET INCOME: 60C - 80C/SHARE
* MARKET CAP = $36M
* P/S RATIO = 0.25
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $40 MILLION
* INSIDERS OWN 54% OF COMPANY
EXXA was a $6+ stock in 2004 with less revenues, less earnings, and three times the long-term debt. More importantly, EXXA did not have a blue chip company like DaimlerChrysler as its largest customer.
2Q 2006 EARNINGS SUMMARY:
REVENUES: $43M .....vs. $37M....2ND QUARTER
NET INCOME: $2.14M OR 19C/SHARE..........vs. $0.7M LAST YEAR
2Q 2006 earnings link:
http://biz.yahoo.com/prnews/060814/dam020.html?.v=62
DaimlerChrysler is now Exx Inc.'s largest customer. The new DaimlerChrysler's contracts will represent about 30 % of the total projected $160M - $180M/year EXXA revenues in 2006.
EXXA has the potential to become the next BOOM. In 2005 Fortune Magazine ranks EXXA as No. 1 in revenue growth, and 8th overall, among America's fastest growing companies.
About The Two DaimlerChrysler Contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis..."
.."In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's annual sales..."
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A
EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003. EXXA recently bought vinyl wallpaper maker Seller Brothers (S&B) from BK ofr $4M. EXXA expects S&B to be immediately acreetive to earnings and net income.
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing of a variety of products, principally for the automotive, heavy-duty, agricultural, industrial, and defense markets. Newcor reports its businesses under two product segments: Precision Machined Products and Rubber and Plastic Products. Newcor also operates the Bay City Division, which designs and builds state-of-art welding and forming equipment.
The following link describes some of Bay City Automotive-component development and production capabilities..
http://www.baycity.newcor.com/autocomp.htm
DYNT $1.25 COULD BE AN EASY DOUBLE....CHECK IT OUT
SAFE INVESTMENT. STRONG PROFITABLE 2007 PREDICTED. STOCK BUYBACK ONGOING. LOW FLOAT. MANY NEW PRODUCTS LAUNCHED AND TO BE LAUNCHED. STRONG BALANCE SHEET. TRADING AT 0.5/P/S.
EARNINGS IN 4 WEEKS.
6-month Target:$3
Dynatronics (Nasdaq: DYNT) recently reported another profitable year for FY 2006. 2007 is looking like it will be a strong year for DYNT.
DYNT's CEO predicted at least 10% revenue growth and a substantial increase in net income.....1Q 2007 will be reported in about 6 weeks.
From the earnings release and CC:
-- DYNT was profitable again. The company invested an all-time record amount in R&D in 2006.
-- The positive effect of the many new products launched, and to be launched in the next few weeks, on revenues and net income will start showing up in Q1 2007 to be reported in early November 2006.
-- DYNT will lower R&D expenses by about 5c/share in 2007 from 2006's record levels.
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED and PATENTED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
* STOCK BUYBACK IS ONGOING.
-- The company believes the stock is undervalued and has triggered its stock-buyback program. About 50K shares have been purchased in the open market in 2006. DYNT has cash authorized to buy 250K more shares. the company activates its buyback program when the stock dips under $1.3.
-- Two major new products will be launched in October/November 2006.
-- Based on the new product launches and reduced R&D costs, DYNT expects at least a 10% revenue growth and substatially higher net income. I believe net income will range from 10 -15c/share in 2007.
SELECTED COMPANY COMMENTS FROM 2006 EARNINGS RELEASE and CC
..."New products introduced during the past year include the Dynatron 702, a stand-alone light therapy device, as well as the new DX9 combination traction and light therapy system. The DX9 system combines the benefits of infrared light therapy using the Dynatron 702 with decompression therapy using the Company's TX900 Traction device. This unique combination of modalities has been reported to be highly effective in the treatment of back pain..."
"Dynatronics also introduced the Dynatron Xp light pad in 2006. This popular product is capable of treating a much larger area than can be treated by other devices. It is 14 times more powerful than light probes currently on the market and makes unattended patient therapy possible..."
"Looking ahead to fiscal 2007, we are pleased to have begun the year with the July 2006 introduction of the new Dynatron X3 infrared light therapy device," said Larry K. Beardall, executive vice president for sales and marketing. "In addition, we plan to introduce the much anticipated DX2 proprietary traction device soon. The DX2 incorporates patent-pending technology and will utilize the new T4 treatment table which is specially designed for traction and decompression therapies. The T4 treatment table is scheduled for introduction in November 2006."
The new DX2 is currently undergoing clinical beta testing and has been previewed at several national trade shows. "Interest in the DX2 from practitioners at the national trade shows has been substantial," reported Beardall. "While the development effort has taken longer than anticipated, we believe this innovative approach to treating back pain will prove to be a great benefit to patients."
ABOUT DYNT:
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. In fact, it was widely publicized that one of Dynatronics' light therapy probes was use to accelerate Terrel Owens' amazing recovery in time to play in the Superbowl a couple of years ago.
Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
DYNT $1.3 WILL REPORT 4Q 2006 EARNINGS NEXT WEEK....... GREAT ENTRY POINT UNDER $1.5
TARGET: $3++ by YEAR END
Earnings for the quarter and for the year 2006 will be decent, still pritable, but not great ...and that is one of the reasons why it is trading in the low $1's. However, it is likely that DYNT will have several strong quarters starting with 1Q 2007 to be reported in early November. Early this month, DYNT released its high-margin and long-awaited Dynatron X3 Light Therapy Unit.
Mr. Cullimore, President of Dynatronics said about this release.."While we have been delayed in releasing the new X3 product, we are confident the market will be pleased with the outcome. The delay has created a backlog of orders that we hope to resolve over the next few weeks,"
The company belives that the stock is undervalued and is buying back stock in the open market. Mr Cullimore said:
..."On another front, the $500,000 stock buy-back program that was announced by Dynatronics is well underway. The company is again actively purchasing its common shares on the open market. Since announcing the program in 2003, Dynatronics has purchased 134,000 shares of common stock in the open market. "Reactivating our stock repurchase program highlights the current undervaluation of our stock,"
That's the type of confidence that you don't hear from companies trading this low. Now that investors are looking for safe investment, they will be hard pressed to find safer investments than DYNT at these prices.
Here is the release that explains about the X3 and the stock buyback:
http://biz.yahoo.com/prnews/060803/lath058.html?.v=64
DYNT HIGHLIGHTS:
* DYNT IS THE LEADER IN LIGHT THERAPY FOR PAIN MANAGEMENT
* FDA APPROVED PRODUCTS
* NEW PRODUCTS WILL YIELD SUBSTANTIAL GAINS IN REVENUE AND NET INCOME STARTING with 1Q 2007 WITH TOMORROW'S NUMBERS.
* PROFITABLE AND TRADING AT 0.5 P/S
* STRONG BALANCE SHEET
DYNT is the leader in the area of light therapy for pain management. DYNT's Light therapy products are FDA-approved. In fact, it was widely publicized that one of Dynatronics' light therapy probes was use to accelerate Terrel Owens' amazing recovery in time to play in the Superbowl a couple of years ago.
DYNT has started shipping several new pain-management products in recent months and are expected to boost revenues and net income starting in 1Q 2007 to be reported in early November 2006. DYNT had never before launched so many new products before. Revenue and net income usually jump in the quarters following the deployment of new products.
Because light therapy is non-invasive and does not have adverse effects, it is an ideal replacement for dangerous drugs like Vioxx, and Celebrex to address Rheumatism and similar types of pain. Light therapy is also used for carpal syndrome and a number of muscle/nerve/bone types of pain.
Light Therapy has been used extensively throughout the world for more than twenty years. Also known as cold laser or phototherapy, Light Therapy is backed by extensive research with over 500 published studies covering a number of soft-tissue injuries, pain, and inflammatory conditions.
DYNT has introduced a number of new state-of-the-art pain management products at the end of last quarter and this quarter:
New products include the Dynatron X3 multiple modality infrared light therapy device, the DX2 proprietary traction device that incorporates unique technology, and the T4 therapy table specially designed for performing traction and decompression therapies. These products will expand the range of decompression and light therapy treatment options for treating back pain.
"The introduction of these state-of-the-art products will give additional impetus to the growth of sales and profits in future quarters," added CEO Cullimore......
Insiders have been loading up lately, and the company has been buying stock in the open market.
Do your DD
Nsomniyak....thank you for your analisys. You are not nmissing anything. EXXA is super-undervalued (even with the recent mini rally) because people did not know about it. That's is changing as we speak. Wait until they post another 15 - 25 c/net income next quarter....then you will see $6 plus easily.
EXXA $3.16...NEW 2-YEAR HIGH...VOLUME INCREASING
EXXA was one of AMEX largest % gainers yesterday and today.....take a look at the long-term uptrend on the lower (weekly) chart:
http://stockcharts.com/gallery/?EXX/A
EXXA posted a 19c/share net income on $43M in revenues (30% increase) last week. The new $45M/year DaimlerChrysler contract and the recent acquisition of Sellers Brothers are starting to have a strong effect in revenues and net income.
EXXA's numbers are mind boggling...for under $5 stock....it reminds me of BOOM before it exploded.
...60 - 80c/share annualized net income
...$45m/year multi-year contract with DaimlerChrysler
...$170M/Year in revenues
...Less than $40M market cap
...Only 4.7M share on the float
...Less than 12M total outstanding shares
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A. EXXA will go Nasdaq and that will increase liquidity and visibility tremendously.
EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market.
The 60+c/share annualized net income might actually be conservative. In addition to net income coming in from DCX, EXXA acquired Sellers Brothers from BK for a song in 1Q 2006. Sellers Brothers, a vinyl cover, seats, wallpaper..etc..manufacturer is now contributing to the top and bottom lines. The DCX work is maxed out and company expects this situation to continue for several more quarters.
Furthermore, EXXA is one the most profitable companies in the sector if they keep that up. If it was to be acquired, I can see someone paying more than $100M for it...or about 70% of sales...that equates to $10/share. For some reason the CEO keeps buying shares in the open market even though he own more than 40% of all O/S shares. I believe he expect something big to happen ..soon...the guy is in his late 60's.
do your DD before EXXA becomes a BOOM or a DXPE
EXXA $3.2....NEW 2-YEAR HIGH...BREAKING OUT...RADAR IT....
EXXA posted a 19c/share net income on $43M in revenues (30% increase) last week. The new $45M/year DaimlerChrysler contract and the recent acquisition of Sellers Brothers are starting to have a strong effect in revenues and net income.
Today EXXA is one of AMEX largest % gainers.
http://stockcharts.com/gallery/?EXX/A
EXXA's numbers are mind boggling...for under $5 stock....it reminds me of BOOM before it exploded.
...60 - 80c/share annualized net income
...$45m/year multi-year contract with DaimlerChrysler
...$170M/Year in revenues
...Less than $40M market cap
...Only 4.7M share on the float
...Less than 12M total outstanding shares
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A. EXXA will go Nasdaq and that will increase liquidity and visibility tremendously.
EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market.
The 60+c/share annualized net income might actually be conservative. In addition to net income coming in from DCX, EXXA acquired Sellers Brothers from BK for a song in 1Q 2006. Sellers Brothers, a vinyl cover, seats, wallpaper..etc..manufacturer is now contributing to the top and bottom lines. The DCX work is maxed out and company expects this situation to continue for several more quarters.
Furthermore, EXXA is one the most profitable companies in the sector if they keep that up. If it was to be acquired, I can see someone paying more than $100M for it...or about 70% of sales...that equates to $10/share. For some reason the CEO keeps buying shares in the open market even though he own more than 40% of all O/S shares. I believe he expect something big to happen ..soon...the guy is in his late 60's.
do your DD before EXXA becomes a BOOM or a DXPE
Gilead...the 60c/share net income is conservative. In addition to net income coming in from DCX, EXXA acquired Sellers Brothers from BK for a song in 1Q 2006. Sellers Brothers, a vinyl cover, seats, wallpaper..etc..manufacturer is now contributing to the top and bottom lines. The DCX work is maxed out and company expects this situation to continue for several more quarters. There are rumors that DCX might award even more contracts because they are happy with the quality, timeliness, and workmanship of the products coming out of Newcor. Coincidentally, a investor from stuttgard.....Mercedes'headquarters...bought 80K shares a couple of weeks ago. Why??.....i don't know.....but there could be a connection there.
Furthermore, EXXA is one the most profitable companies in the sector if they keep that up. If it was to be acquired, I can see someone paying more than $100M for it...or about 70% of sales...that equates to $10/share. For some reason the CEO keeps buying shares in the open market even though he own more than 40% of all O/S shares. I believe he expect something big to happen ..soon...the guy is in his late 60's.
EXXA REPORTED 2Q 2006 19C/SHARE NET INCOME ON $43M REVENUES ...A 30% INCREASE. DAIMLERCHRYSLER NOW EXXA's LARGEST CUSTOMER (25%)
The numbers are mind boggling...it reminds me of BOOM/DXPE before they exploded.
...80c/share annualized net income
...$45m/year multi-year contract with DaimlerChrysler
...$170M/Year in revenues
...Less than $40M market cap
...Only 4.7M share on the float
...Less than 12M total outstanding shares
And trading less than $10/share..actually less than $3???
The most difficult part about investing in EXXA is to figure out the symbol used by the various brokers. Etrade and Ameritrade use EXX.A..........Scottrade uses EXX/A..... MerrillLynch uses EXX'A. EXXA will go Nasdaq and that will increase liquidity and visibility tremendously.
EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
EXX/A $2.9 REPORTED 19C/SHARE NET INCOME...30% REVENUE GROWTH!!!
EXX/A REPORTED A BLOCKBUSTER 2ND QUARTER YESTERDAY...THE MARKET IS NOT FULLY AWARE OF THIS YET. EXXA WILL BE A $10++ STOCK SOON.
ONLY 3.8M SHARE FLOAT........HUGE INSIDER BUYING
DAIMLERCHRYSLER IS NOW EXXA'S LARGEST CUSTUMER WITH TOW H\UGE CONTRACTS ANNOUNCED LAST YEAR. DCX PROFITS ARE STARTING SHOW UP BIG TIME IN THE TOP AND BOTTOM LINES.
2Q 2006 EARNINGS SUMMARY:
REVENUES: $43M .....vs. $37M....2ND QUARTER
NET INCOME: $2.14M OR 19C/SHARE..........vs. $0.78M LAST YEAR
http://biz.yahoo.com/prnews/060814/dam02...
EXXA HIGHLIGHTS:
* LOW FLOAT = 4.7 MILLION SHARES
* 2005 REVENUES = $147 MILLION
* 2006 NET INCOME = 22C/SHARE.....FIRST SIX MONTHS
* O/S SHARES = 11.3 MILLION
* MARKET CAP = $40MILLION
* INSIDERS OWN 54% OF COMPANY
* HEAVY INSIDER BUYING
DaimlerChrysler is now Exx Inc.'s largest customer. The new DaimlerChrysler's contracts will represent about 30 % of the total projected $160M - $180M/year EXXA revenues in 2006.
EXXA has the potential to become the next BOOM. In 2005 Fortune Magazine ranks EXXA as No. 1 in revenue growth, and 8th overall, among America's fastest growing companies.
About The Two DaimlerChrysler Contracts (Per the 2005 10-K) :
..."In May 2005, the Company reported that one of the subsidiaries of Newcor received purchase orders from Daimler Chrysler Corporation ("DCX") to machine axles for two current powertrain programs. the anticipated sales would approximate a 20% increase over the Company's then sales and profitability on an annual basis.
In June 2005, the Company reported that a second subsidiary of Newcor had been awarded a machining program for a DCX powertrain. The annual sales of this program were estimated at approximately 10% of the Company's 2004 annual sales.
Based on the new contracts from DCX it is anticipated that DCX will become Newcor's largest customer."
EXXA's Chairman/CEO David Segal is very bullish about the future of EXXA's stock. He has recently added 102,700 shares to his 5M plus shares buying all those shares in the open market!!
http://www.sec.gov/Archives/edgar/data/8...
ABOUT EXXA:
Newcor, EXXA's largest division, was founded in 1933 as National Electric Welding Machines Company and changed its name to Newcor in 1969. EXXA snatched NEWCOR from BK in 2003. EXXA recently bought vinyl wallpaper maker Seller Brothers (S&B) from BK ofr $4M recently. EXXA expects S&B to be immediately acreetive to earnings and net income.
Newcor, Inc., owns several divisions employing over 1000 people worldwide in all areas of design, engineering, and manufacturing of a variety of products, principally for the automotive, heavy-duty, agricultural, industrial, and defense markets. Newcor reports its businesses under two product segments: Precision Machined Products and Rubber and Plastic Products. Newcor also operates the Bay City Division, which designs and builds state-of-art welding and forming equipment.
CSTL $3.0 MOVING UP..EARNINGS THIS WEEK...SOLID LOW FLOATER CSTL COULD BE A BIG GAINER THIS WEEK AFTER EARNINGS.
CSTL, with only 1.8m shares in the float and $1.6/share cash and ZERO debt, will report 2Q 2006 earnings this week.
CSTL's CEO Mr. MacDonald issued the following bullish update a few weeks ago:
http://biz.yahoo.com/bw/060505/200605050...
Recent insider buying is also encouraging:
http://www.secform4.com/insider/showhist...
On April 26, 2006, VSTL reported its 12th consecutive profitable quarter. CSTL's 1Q 2006 was the best quarter since 2000. Following sequential revenue increases the prior three quarters.
1 Q 2006 EARNINGS SUMMARY:
-- 1Q 2006 Revenues $2.99M vs. $2.59M...up 15%
-- 1Q 2006 Net income 5c/share vs. 3c/share in 1Q 2005.
-- $7.14M cash or $1.6/share...Up $640K From 1Q 2005.
-- ZERO DEBT
*** CSTL HIGHLIGHTS:
- Float: 1.8M shares
- Outstanding shares: 4M
- Market cap $13M
- P/S of 1.15
- P/E less than 15
REGARDING 1Q 2006, Mr. MACDONALD SAID"
"Our first quarter of 2006 was a clear reflection of Castelle's successful expansion into the enterprise market with FaxPress Premier(TM)," ...... "FaxPress Premier has been a significant contributor in helping Castelle capture additional market share, and has been one of the key drivers behind our revenue and earnings growth. Also in the first quarter, Castelle introduced a more robust digital fax server, FaxPress Enterprise(TM), to support the increasing demand for installations in digital environments. FaxPress(TM), FaxPress Premier and FaxPress Enterprise have been well received by new and existing customers worldwide, and we look forward to expanding our share of the fax server market."
Castelle Continues to Strengthen its Balance Sheet
Castelle's balance sheet as of March 31, 2006 reported cash and cash equivalents of $7.14 million, up 5.6% from December 31, 2005. This translates to nearly $1.59 per fully diluted share. Cash has not been at this level since the second quarter of 1997. Castelle remains free of long-term debt.
Strategic Partnerships to Support New Growth Initiatives
Castelle has recently taken several significant steps to expand its product offerings and establish new solution partnerships. In addition to the introduction of FaxPress Enterprise in March, Castelle announced that FaxPress Premier has been approved by Fujitsu Limited as an "Interstage® Enabled" product in Japan. In April, Castelle announced the integration of its fax servers with Ricoh's new GlobalScan 2.0 software to provide a complete fax solution for all electronic and paper-based documents.
ABOUT CSTL:
Castelle (Nasdaq:CSTL - News), a market leader in "all-in-one" network fax solutions for business and enterprise, develops office automation systems that allow organizations to easily implement faxing over local area networks and the Internet. Castelle's network fax servers, FaxPress(TM), FaxPress Premier(TM), and FaxPress Enterprise(TM) provide a simple way to integrate fax with email, desktop and back-end applications. Castelle products are designed to be easy to use and maintain, and provide an economical way for companies to share resources over the network. Castelle was founded in 1987 and is headquartered in Morgan Hill, California. Its products are available through a worldwide network of distributors, resellers, and online retailers. Visit Castelle online at www.castelle.com.